Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease

Hesse, W.H.; Rudofsky, G.; Peskar, B.A.

Wiener Klinische Wochenschrift 103(18): 554-557

1991

ISSN/ISBN: 0043-5325
PMID: 1750222
Document Number: 4341
Using high performance liquid chromatography and radioimmunoassay we have investigated the stability of prostaglandin (PG) E1 and its metabolite 13,14-dihydro-PGE1 in human plasma as well as the initial metabolism of PGE1 infused intravenously (80 micrograms/patient/hour) in patients with peripheral arterial occlusive disease. 13,14-dihydro-PGE1 degraded like PGE1 in human plasma at 37 degrees C with a half-life of several hours. During infusion of PGE1 higher plasma concentrations of the major metabolite 15-keto-13,14-dihydro-PGE1 and lower plasma levels of PGE1 and 13,14-dihydro-PGE1 were observed. The metabolite 13,14-dihydro-PGE1 is of interest, since in contrast to 15-keto-13,14-dihydro-PGE1 it is biologically active. The biosynthesis of 13,14-dihydro-PGE1 could contribute to the therapeutic efficacy of PGE1 administered intravenously in patients with peripheral arterial occlusive disease.

Document emailed within 1 workday
Secure & encrypted payments

Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease

Kiesewetter, H.; Jung, F.; Erdlenbruch, W.; Wenzel, E. 1992: Haemodilution in patients with peripheral arterial occlusive disease International Angiology: a Journal of the International Union of Angiology 11(3): 169-175
Chen, H.-W.; Liu, H.-E. 2011: Peripheral arterial occlusive disease and its care in hemodialysis patients Hu Li Za Zhi Journal of Nursing 58(2): 16-21
Dormandy, J.A. 1992: Natural history of patients with peripheral occlusive arterial disease Annales Chirurgiae et Gynaecologiae 81(2): 86-88
Womack, C.J.; Sieminski, D.J.; Katzel, L.I.; Yataco, A.; Gardner, A.W. 1997: Improved walking economy in patients with peripheral arterial occlusive disease Medicine and Science in Sports and Exercise 29(10): 1286-1290
Sabbá, C.; Zupo, V.; Dina, F.; Nazzari, M.; Albano, O. 1988: A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease International Journal of Clinical Pharmacology Therapy and Toxicology 26(5): 249-252
2002: New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long MMW Fortschritte der Medizin 144(21): 54
Mirenda, F.; La Spada, M.; Baccellieri, D.; Stilo, F.; Benedetto, F.; Spinelli, F. 2005: Iloprost infusion in diabetic patients with peripheral arterial occlusive disease and foot ulcers Chirurgia Italiana 57(6): 731-735
Böger, R.H.; Bode-Böger, S.M.; Thiele, W.; Junker, W.; Alexander, K.; Frölich, J.C. 1997: Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease Circulation 95(8): 2068-2074
Lebrun, T.; Selke, B.; Sailly, J.C.; Boissier, C.; Mosnier, M. 1994: The introduction of economic criteria into the management of arterial disease: an illustration with regard to the socioeconomic consequences of peripheral occlusive arterial disease of the lower limbs Journal of Cardiovascular Pharmacology 23(Suppl 3): S17-S21
Roller, R.E.; Trinker, M.; Schnedl, W.J.; Pilger, E.; Korninger, C. 1999: Lack of association between elevated serum Lp(a) and local thrombus lysability in patients with peripheral arterial occlusive disease Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 10(7): 449-450
Klieber, M.; Resch, F. 1986: Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease Wiener Klinische Wochenschrift 98(3): 70-73
Cole, C.W.; Hill, G.B.; Farzad, E.; Bouchard, A.; Moher, D.; Rody, K.; Shea, B. 1993: Cigarette smoking and peripheral arterial occlusive disease Surgery 114(4): 753
Kröger, K. 2005: Peripheral arterial occlusive disease--the forgotten arteriosclerosis MMW Fortschritte der Medizin 147(18): 21
Spittell, J.A. 1982: Diagnosis and treatment of occlusive peripheral arterial disease Geriatrics 37(1): 57-67
Spittell, J.A. 1992: Conservative management of occlusive peripheral arterial disease Cardiovascular Clinics 22(3): 209-215
Kiesewetter, H.; Jung, F. 1984: Hemorheologic therapy in peripheral arterial occlusive disease Fortschritte der Medizin 102(37): 921-924
Périard, D.; Hayoz, D.; Mazzolai, L. 2009: Medical therapy in peripheral arterial occlusive disease Revue Medicale Suisse 5(189): 312-315
Sailer, S.; Pilger, E. 1985: Fibrinolytic therapy of peripheral arterial occlusive disease Wiener Medizinische Wochenschrift 135(15-16): 393-399
Ratnatunga, C. 1998: Chronic peripheral occlusive arterial disease in Sri Lanka Ceylon Medical Journal 43(4): 182-184
Johnston, K.W.; Colapinto, R.F.; Harries-Jones, E.P.; DeMorais, D.; Kalman, P.G.; Baird, R.J.; Goldman, B.S.; Key, J.A.; Weisel, R.D. 1980: Transluminal dilatation in the treatment of peripheral arterial occlusive disease Canadian Journal of Surgery. Journal Canadien de Chirurgie 23(6): 547-548